Treatment of progressive supranuclear palsy with tricyclic antidepressants.

Abstract

After a single patient with progressive supranuclear palsy (PSP) improved when given amitriptyline, we compared the effects of amitriptyline, desipramine, and placebo on the symptoms and signs of four patients with PSP in a double-blind, double-crossover manner. There was good correlation between the use of tricyclic agents and symptomatic improvement, although all patients remained disabled. Amitriptyline produced better overall improvement, whereas desipramine preferentially improved apraxia of eyelid opening.

• Authors: G C Newman
• Journal: Neurology (Neurology) Vol. 35 Issue 8 Pg. 1189-93 (Aug 1985) ISSN: 0028-3878 [Print] United States
• PMID: 3895032 (Publication Type: Case Reports, Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article)

Chemical References

• Antidepressive Agents, Tricyclic
• Amitriptyline
• Desipramine

Topics

• Aged
• Amitriptyline (therapeutic use)
• Antidepressive Agents, Tricyclic (therapeutic use)
• Bulbar Palsy, Progressive (drug therapy, physiopathology)
• Clinical Trials as Topic
• Desipramine (therapeutic use)
• Disability Evaluation
• Eye Movements (drug effects)
• Female
• Humans
• Male
• Middle Aged